TABLE 4.
Carrier Count |
ADEH− vs NA |
ADEH+ vs ADEH− |
ADEH+ vs NA |
TGP Frequency (Ref/Alt) |
||||
---|---|---|---|---|---|---|---|---|
FLG Variant | ADEH+ | ADEH− | NA | OR [95% CI] p-value |
OR [95% CI] p-value |
OR [95% CI] p-value] |
AFR AMR EAS EUR SAS |
|
S3247X (WT = CC; MUT = AA) (rs150597413) |
GG | 48 | 481 | 236 | 4.87 [0.7–213.6] 0.116 |
1.00 [0.02–7.3] 1 |
4.88 [0.06–386.2] 0.3136 |
G/T |
100%/0% | ||||||||
100%/0% | ||||||||
100%/0% | ||||||||
GT | 1 | 10 | 1 | 99.8%/0.2% | ||||
TT | 0 | 0 | 0 | 100%/0% | ||||
R2447X (WT = CC; MUT = TT) (rs138726443) |
GG | 46 | 474 | 237 | 17.20 [undefineda] 0.0026 |
1.79 [0.3–6.6] 0.4165 |
34.78 [undefineda] 0.0049 |
G/A |
100%/0% | ||||||||
99.7%/0.3% | ||||||||
100%/0% | ||||||||
GA | 3 | 17 | 0 | 99.7%/0.3% | ||||
AA | 0 | 0 | 0 | 100%/0% | ||||
R501X (WT = CC; MUT = TT) (rs61816761) |
GG | 38 | 428 | 230 | 4.66 [2.1–10.2] 0.0001 |
1.65 [0.8–3.2] 0.1377 |
8.44 [3.1–22.7] 2.4957×10−5 |
G/A |
99.8/0.2% | ||||||||
99.4/ 0.6% | ||||||||
100/0% | ||||||||
GA | 11 | 58 | 7 | 99.0/1.0% | ||||
AA | 0 | 5 | 0 | 99.9/0.1% | ||||
2282del4 (MUT = delCAGT) |
WT | 40 | 419 | 225 | 3.14 [1.7–5.8] 0.0003 |
1.21 [0.6–2.4] 0.5917 |
3.98 [1.6–10.2] 0.0038 |
NA |
HET | 7 | 65 | 12 | |||||
MUT | 1 | 7 | 0 | |||||
3702delG (MUT = delG) |
No Carriers for this deletion in the dataset. | NA |
Abbreviation: NA, variant not found in TGP.
CI could not be estimated due to 0 genotype counts in the control category. Allele frequencies were obtained for Phase 3 release of TGP for five super-populations: AFR (African), AMR (Admixed American), EAS (East Asian), EUR (European), and SAS (South Asian). The frequencies were obtained from the Human (GRCh37.p13) genome on Ensembl.